by Peer M. Schatz
Volume 6, Issue 3 (Fall 2007)
When analyzing the complete market for human diagnostic products, with an estimated value of $30 billion annually, the $2 billion market for molecular diagnostic methods is still relatively small. However, with a growth rate of 20% per year, this segment is growing faster than any other in in vitro diagnostics. The reason for this is that healthcare systems have just begun tapping the tremendous potential to which this new technology gives us access. Whereas in the past, large reference laboratories and academic teaching hospitals were the driving force, today the customer base is increasingly made up of smaller diagnostic labs and clinics. Other features of the market are the wide-reaching protection of intellectual property and high product values, due to the significantly higher development and production costs…
Citation:
Schatz PM. The Growing Molecular Diagnostics Market. BioProcess J, 2007; 6(3): 56-57. http://dx.doi.org/10.12665/J63.Schatz